CD103 Deficiency Prevents Graft-versus-Host Disease but Spares Graft-versus-Tumor Effects Mediated by Alloreactive CD8 T Cells

• Kechang Liu ,

  Contributed equally to this work with: Kechang Liu, Bryan A. Anthony

  Affiliation Department of Microbiology and Immunology, University of Maryland Medical School, Baltimore, Maryland, United States of America

  ⨯
• Bryan A. Anthony ,

  Contributed equally to this work with: Kechang Liu, Bryan A. Anthony

  Affiliation Department of Surgery, The Ohio State University, Columbus, Ohio, United States of America

  ⨯
• Martha M. Yearsly,

  Affiliation Department of Pathology, The Ohio State University, Columbus, Ohio, United States of America

  ⨯
• Mehdi Hamadani,

  Affiliation Department of Hematology and Oncology, West Virginia University, Morgantown, West Virginia, United States of America

  ⨯
• Alice Gaughan,

  Affiliation Department of Surgery, The Ohio State University, Columbus, Ohio, United States of America

  ⨯
• Jiao-Jing Wang,

  Affiliation Department of Surgery, The Ohio State University, Columbus, Ohio, United States of America

  ⨯
• Steven M. Devine,

  Affiliation Department of Hematology and Oncology, Arthur G. James Comprehensive Cancer, The Ohio State University, Columbus, Ohio, United States of America

  ⨯
• Gregg A. Hadley

  * E-mail: gregg.hadley@osumc.edu

  Affiliation Department of Surgery, The Ohio State University, Columbus, Ohio, United States of America

  ⨯